Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.

doi:10.1002/jcla.24626

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.

Journal of clinical laboratory analysis - 1 Sept 2022

Liao Shenling, An Kang, Liu Zhi, He He, An Zhenmei, Su Qiaoli, Li Shuangqing

Abstract excerpt

INTRODUCTION: We aimed to confirm the association between some single nucleotide polymorphisms (SNPs) and metabolic dysfunction-associated fatty liver disease (MAFLD) in western China. METHODS: A total of 286 cases and 250 healthy controls were enrolled in our study. All samples were genotyped for patatin-like phospholipase domain containing 3 (PNPLA3) rs738409, transmembrane 6 superfamily member 2 (TM6SF2)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Lipase

Share to Liver

Share to Liver Diseases

Share to Membrane Proteins

Share to Non-alcoholic Fatty Liver Disease

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 35881683
DOI: 10.1002/jcla.24626
PMCID: PMC9459258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.PMID 35881683Read ↗

Advances in genetic variation in metabolism-related fatty liver diseaseSemantic proximity Read ↗

Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.Semantic proximity Read ↗

Genetic variants associated with metabolic dysfunction-associated fatty liver diseases in a Korean populationSemantic proximity Read ↗

Analysis of TM6SF2, PNPLA3, and ATG16L1 Genetic Variants in MASLD and MASH: An Egyptian Case-control StudySemantic proximity Read ↗

Update on genetics and epigenetics in metabolic associated fatty liver diseaseSemantic proximity Read ↗

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity Read ↗

Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population.Semantic proximity Read ↗

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and TherapeuticsSemantic proximity Read ↗

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.Semantic proximity Read ↗

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population.Semantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.